Case Study: How A Multi-Drug Combo For Companion Animals Was Developed And Commercialized

Business Problem

One of our leading multi-national animal healthcare clients was working on a novel three-drug combination product for the treatment of seasonal ticks in companion animals.

The client wanted to stabilise a low dose drug which is highly prone to hydrolytic degradation, and also ensure content uniformity of the active within the microgram dosage. The problem was unique and challenging, as the tabletting adjuvants were incompatible, and required our team to think outside the box to develop a stable formulation composition.